NXERA PHARMA CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4565 for the last quarter is 9.26 B JPY, and it's 14.23% higher compared to the previous quarter. The net income of Q3 24 is 1.20 B JPY.